345 results on '"Gómez‐De‐León, Andrés"'
Search Results
2. Outpatient ATG-free hematopoietic transplantation for aplastic anemia in limited-resource environments offers excellent results: Data from a single LATAM center
3. Increasing access to transplantation through telemedicine and patient navigation
4. Long-Term Efficacy of High-Dose Imatinib in Hispanic Patients Without Access to Second-Generation Tyrosine Kinase Inhibitors Treated in LATAM Centers
5. Lactate dehydrogenase as a hematopoietic stem cell mobilization biomarker in autologous transplantation
6. Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study
7. Vinblastine as a bridge to 7 + 3 in acute myeloid leukaemia
8. Oseltamivir as rescue therapy for persistent, chronic, or refractory immune thrombocytopenia: a case series and review of the literature
9. Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012
10. Treatment of Ph-Negative Acute Lymphoblastic Leukemia in Adolescents and Young Adults with an Affordable Outpatient Pediatric Regimen
11. Bringing Global Hematology Research to the Forefront
12. Lesson learned in pediatric haploidentical transplantation in a low-resource environment: delivering melphalan IV and using low dose radiation reduce graft failure
13. Time to define and refine maintenance strategies in acute myeloid leukaemia
14. Results of treating relapsed and refractory acute myeloid leukemia at a reference center in Latin America: the importance of outpatient hematopoietic stem cell transplantation
15. Outpatient transplantation in the COVID-19 era: a single-center Latin American experience
16. Obstacles to global implementation of CAR T cell therapy in myeloma and lymphoma.
17. The consequences of delayed diagnosis and treatment in persons with multiple sclerosis given autologous hematopoietic stem cell transplantation
18. Graft-versus-host disease after an outpatient peripheral blood hematopoietic cell transplant using reduced-intensity conditioning: a single-center LATAM experience
19. Corrigendum to “Outpatient ATG-free hematopoietic transplantation for severe aplastic anemia in limited-resource environments offers excellent results: Data from a single LATAM center” [Blood Cells, Mol. Dis. 109 (2024) 102885]
20. Danazol as First-Line Therapy for Myelodysplastic Syndrome
21. Contributions to the American Society of Hematology Meeting From Low- and Middle-Income Countries: An In-Depth Analysis and Call to Action
22. Treating Acute Leukemia During the COVID-19 Pandemic in an Environment With Limited Resources: A Multicenter Experience in Four Latin American Countries
23. Age Acts as an Adverse Independent Variable for Survival in Acute Lymphoblastic Leukemia: Data From a Cohort in Northeast Mexico
24. TNF-α increases in the CSF of children with acute lymphoblastic leukemia before CNS relapse
25. Acute Leukemia Characteristics are Different Around the World: the Mexican Perspective
26. Acute myeloid leukemia: challenges for diagnosis and treatment in Latin America.
27. Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Safe and Feasible
28. Is There Still a Role for Low-Dose All-Transretinoic Acid in the Treatment of Acute Promyelocytic Leukemia in the Arsenic Trioxide Era?
29. Feasibility and Improvement in Survival with a Risk-Adapted Treatment Regimen for Childhood Acute Lymphoblastic Leukemia in a Limited Resource Setting
30. Lactate dehydrogenase as a hematopoietic stem cell mobilization biomarker in autologous transplantation
31. Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial
32. MDS-460 Impact of Venetoclax on High-Risk Myelodysplastic Syndromes: A Retrospective Multicenter Analysis of Azacitidine-Venetoclax vs Azacitidine Monotherapy in Mexico
33. Impact of Venetoclax on High-Risk Myelodysplastic Syndromes: A Retrospective Multicenter Analysis of Azacitidine-Venetoclax vs Azacitidine Monotherapy in Mexico
34. The consequences of delayed diagnosis and treatment in persons with multiple sclerosis given autologous hematopoietic stem cell transplantation
35. Diagnosis and treatment of acute lymphoblastic leukemia in Latin America
36. Alternatives for managing patients with newly diagnosed immune thrombocytopenia: a narrative review
37. Hematopoietic Stem Cell Transplantation Activity for Lymphoma: A Multicentric Study By the Transplantation and Cellular Therapy Mexican Working Group
38. Hematopoietic Cell Transplantation in First Remission in AML in Mexico: Very Low Rates Derived from Early Relapses and Lack of Access
39. An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia
40. Measurements of Catheter, Venous, and Capillary Cyclosporine A Blood Are Comparable and Useful in Pediatric Hematopoietic Stem Cell Transplant Recipients
41. 308 - Switching to IV Melphalan with or without Low Dose Total Body Irradiation Reduces Primary Graft Failure Rates in Children with Malignancies When Busulfan Monitorization Is Unavailable
42. Cyclophosphamide Split in Two Blocks Apart Renders an Excellent Cardiac Safety Profile during Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis and Other Autoimmune Disorders
43. Outpatient Based Autologous Hematopoietic Stem Cell Transplantation Is a Feasible Therapeutic Option for Patients with Chronic Inflammatory Demyelinating Polyneuropathy: The Mexican Experience
44. Central Venous Access for Peripheral Stem Cell Collection in Autologous Donors: Safety-Related Outcomes of an Outpatient Transplantation Program
45. Socioeconomic Factors Related to Hematopoietic Stem Cell Transplantation for Autoimmune Disorders in North American and European Patients
46. Switching to IV Melphalan with or without Low Dose Total Body Irradiation Reduces Primary Graft Failure Rates in Children with Malignancies When Busulfan Monitorization Is Unavailable
47. Venetoclax-based combinations for acute myeloid leukemia: optimizing their use in Latin-America
48. Perspectivas sobre la terapia CAR-T en México
49. Utilidad de células nucleadas totales para colecta de hematoprogenitores en trasplante autólogo con enfermedades autoinmunes
50. Outpatient allogeneic hematopoietic stem-cell transplantation: a review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.